n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® mPCR FMR1 Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
CFTR
Kit
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
HTT
Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X Syndrome
Dementia
Chronic Myeloid Leukemia (CML)
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
Contact
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
April 3, 2018
Asuragen to Present at 2018 ACMG Annual Clinical Genetics Meeting
Share
January 17, 2018
Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer
Share
November 21, 2017
Asuragen to Present at 29th Annual Piper Jaffray Healthcare Conference
Share
November 8, 2017
Asuragen to Present at Upcoming 2017 Association for Molecular Pathology (AMP) Annual Meeting
Share
October 10, 2017
Asuragen to Present at 2017 American Society of Human Genetics (ASHG) Conference
Share
October 10, 2017
Asuragen CEO to Speak at 2017 World CDx Summit
Share
August 2, 2017
Asuragen Expands QuantideX® qPCR BCR-ABL Portfolio for Monitoring Molecular Response in Chronic Myeloid Leukemia
Share
April 25, 2017
Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio
Share
March 14, 2017
Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space
Share
February 20, 2017
Asuragen and Thermo Fisher Scientific to Collaborate on Diagnostic Kits for 3500 Dx Series Genetic Analyzer
Share
Prev
1
2
3
4
5
6
7
8
Next
About
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Back To
Top
